REN Yan 1,2,3 , HUANG Yunxiang 1,2,3 , ZHANG Yuanjin 1,2,3 , YAO Minghong 1,2,3 , JIA Yulong 1,2,3 , YANG Min 4 , SUN Xin 1,2,3
  • 1. Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, P.R.China;
  • 2. NMPA Key Laboratory for Real World Data Research and Evaluation in Hainan, Chengdu 610041, P.R.China;
  • 3. Sichuan Real World Data Research and Innovation Center, Chengdu 610041, P.R.China;
  • 4. West China School of Public Health, Sichuan University, Chengdu 610041, P.R.China;
SUN Xin, Email: sunx79@hotmail.com
Export PDF Favorites Scan Get Citation

With the establishment and development of regional healthcare big data platforms, regional healthcare big data is playing an increasingly important role in health policy program evaluations. Regional healthcare big data is usually structured hierarchically. Traditional statistical models have limitations in analyzing hierarchical data, and multilevel models are powerful statistical analysis tools for processing hierarchical data. This method has frequently been used by healthcare researchers overseas, however, it lacks application in China. This paper aimed to introduce the multilevel model and several common application scenarios in medicine policy evaluations. We expected to provide a methodological framework for medicine policy evaluation using regional healthcare big data or hierarchical data.

Citation: REN Yan, HUANG Yunxiang, ZHANG Yuanjin, YAO Minghong, JIA Yulong, YANG Min, SUN Xin. Multilevel model and its application in evaluation of medicine policy intervention. Chinese Journal of Evidence-Based Medicine, 2021, 21(12): 1474-1479. doi: 10.7507/1672-2531.202108101 Copy

Copyright © the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved

  • Previous Article

    Construction of an intelligent data integration platform for clinical trials based on information interaction
  • Next Article

    Development of a core traditional Chinese medicine syndromes set for non-valvular atrial fibrillation